Sanofi
OrganizationHeard in 4 episodes across 3 shows since Jul 2026
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. It engages in the research, development, manufacturing, and marketing of therapeutic solutions, with a strong focus on specialty care, vaccines, and general medicines.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 1 |
| Aug 2026 | 1 |
| Sep 2026 | 1 |
| Oct 2026 | 1 |
What experts have said about Sanofi
4 statements · 1 positive · 3 negative
Sanofi will need to replace income when the prior drug patent expires in the early 2030s.
“when that patent begins to expire in early 2030s, they then need to replace that income.”
Open the episode · AG Barr Drops, LandSec Falls, Sanofi GainsListen at 4:19
Sanofi shares rose about 3.7% in Paris after the partnership news.
“shares rising on the back of that, they're up about 3.7% in Paris.”
Open the episode · AG Barr Drops, LandSec Falls, Sanofi GainsListen at 4:27
Sanofi needs to expand its drug pipeline further.
“intensifies that need for that pipeline to be built out more”
Open the episode · SAP Beats, Sanofi Dips, Arcadis GainsListen at 2:50
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring Sanofi, newest first
- Oct 1, 2026
European stocks diverge as property, pharma and cities compete for growthStock MoversOct 1, 2026 - Sep 25, 2026
AI buildout collides with gambling, rates and real-world riskTBPNSep 25, 2026 - Aug 20, 2026
Brain inflammation may be a metabolic problem in disguiseExtend Podcast with Darshan Shah, MDAug 20, 2026 - Jul 24, 2026
Cloud growth boosts SAP while Sanofi dips on halted drug trialStock MoversJul 24, 2026